BioAge Labs, Inc. (BIOA)
10.11
+0.73
(+7.78%)
USD |
NASDAQ |
Aug 25, 16:00
10.12
0.00 (0.00%)
After-Hours: 19:59
BioAge Labs Shareholders Equity (Quarterly) : 374.91M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 374.91M |
| March 31, 2026 | 379.12M |
| December 31, 2025 | 272.05M |
| September 30, 2025 | 277.46M |
| June 30, 2025 | 294.78M |
| March 31, 2025 | 313.17M |
| Date | Value |
|---|---|
| December 31, 2024 | 323.13M |
| September 30, 2024 | 313.75M |
| June 30, 2024 | 145.70M |
| March 31, 2024 | 157.32M |
| December 31, 2023 | -40.67M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| Pfizer Inc. | 85.19B |
| Oramed Pharmaceuticals, Inc. | 317.47M |
| Liquidia Corp. | 195.11M |
| Neumora Therapeutics, Inc. | 44.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.93M |
| Total Liabilities (Quarterly) | 22.02M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 17.19 |
| Net Debt Paydown Yield | 0.13% |